NEW YORK (October 30, 2019) -- Overuse of antibiotics in healthcare contributes to the development of antibiotic-resistant bacteria, resulting in 2 million infections and 100,000 deaths in the U.S. each year, but research is lacking to inform antibiotic stewardship programs aimed at reining in unnecessary use of these powerful drugs, according to a Society for Healthcare Epidemiology of America (SHEA) white paper published today in its journal Infection Control & Hospital Epidemiology.
"Antibiotic stewardship is crucial to maintaining the effectiveness of life-saving treatments and preventing harm to patients and the wider community," said SHEA President Hilary Babcock. "We developed this research agenda to draw attention to serious gaps in our knowledge for future investigators and funders."
Andrew Morris, MD, medical director, Sinai Health System-University Health Network Antimicrobial Stewardship Program, Toronto, and lead author of the white paper, Research Needs in Antibiotic Stewardship, said antibiotic stewardship research is in its infancy, and research funding is needed to move practice forward.
"For most infections, we don't know the optimal drug, dose, or treatment duration. For many, we don't even know if they require antibiotic treatment," Morris said.
The authors acknowledge that Antibiotic Stewardship Programs have gained momentum in hospitals as a powerful tool to address inappropriate antibiotic use, but that the optimal use and full value of these programs has not yet been explored. To address these gaps, the authors highlight four broad categories where gaps exist:
- A scientifically rigorous evidence base to define optimal antibiotic prescribing practices, which adequately inform stewardship interventions across a variety of patient populations and settings;
- Effective stewardship approaches to recognize effective interventions, knowledge of how these interventions can be adapted for implementation both locally and across diverse settings, and an understanding of how interventions can be sustained once implemented;
- Standardized processes and outcome metrics;
- Advanced study designs with appropriate analytic methods, accompanied by infrastructure to support data collection and sharing.
The white paper outlines specific areas where additional clinical evidence is needed to define optimal antibiotic use, including diagnosing and treating pneumonia, urinary tract infections, skin and soft tissue infections, diabetic foot infections, intra-abdominal infections, and prevention of bacterial infections.
"In an effort to combat antibiotic resistance, the federal government, as well as hospitals and health systems, are mandating antibiotic stewardship programs. However, we don't know the optimal staffing for these programs or how they should function," Morris said. The paper notes that nurses have mostly been absent from antibiotic stewardship, and it calls for research to determine how best to engage bedside nurses in stewardship activities.
While further research and investment in antibiotic stewardship is critical to improving and optimizing these strategies, this research falls in the gaps between public health and clinical research, Morris said.
"Because antibiotic stewardship represents the interface of public health, epidemiological research, and clinical research, clear federal funding pathways need to be created. The National Institute of Health funds science but won't fund stewardship because it is largely epidemiologically based and involves public health. The Centers for Disease Control and Prevention funds public health, but it won't fund research that evaluates different interventions," Morris said.
Andrew Morris, Michael Calderwood, Scott Fridkin, Daniel Livorsi, Jessina McGregor, Rebekah Moehring, Lona Mody, Amy Pakyz, Edward Stenehjem, Julia Szymczak, Pranita Tamma. "Research Needs in Antibiotic Stewardship." Infection Control & Hospital Epidemiology. Web (October 30, 2019).
Published through a partnership between the Society for Healthcare Epidemiology of America and Cambridge University Press, Infection Control & Hospital Epidemiology provides original, peer reviewed scientific articles for anyone involved with an infection control or epidemiology program in a hospital or healthcare facility. ICHE is ranked 41st out of 89 Infectious Disease Journals in the latest Web of Knowledge Journal Citation Reports from Thomson Reuters.
The Society for Healthcare Epidemiology of America (SHEA) is a professional society representing more than 2,000 physicians and other healthcare professionals around the world who possess expertise and passion for healthcare epidemiology, infection prevention, and antimicrobial stewardship. The society's work improves public health by establishing infection-prevention measures and supporting antibiotic stewardship among healthcare providers, hospitals, and health systems. This is accomplished by leading research studies, translating research into clinical practice, developing evidence-based policies, optimizing antibiotic stewardship, and advancing the field of healthcare epidemiology. SHEA and its members strive to improve patient outcomes and create a safer, healthier future for all. Visit SHEA online at http://www.
About Cambridge University Press
Cambridge University Press is part of the University of Cambridge. It furthers the University's mission by disseminating knowledge in the pursuit of education, learning and research at the highest international levels of excellence. Its extensive peer-reviewed publishing lists comprise 45,000 titles covering academic research, professional development, over 400 research journals, school-level education, English language teaching and bible publishing. Playing a leading role in today's international market place, Cambridge University Press has over 50 offices around the globe, and it distributes its products to nearly every country in the world. For further information about Cambridge University Press, visit Cambridge.org.